AstraZeneca PLC (LON: AZN)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5,840	6,166	6,329	7,832	5,369
Short-Term Investments	20	239	69	160	849
Cash & Cash Equivalents	5,860	6,405	6,398	7,992	6,218
Cash Growth	-8.51%	0.11%	-19.94%	28.53%	9.47%
Receivables	8,407	7,212	10,758	3,806	3,585
Inventory	5,424	4,699	8,983	4,024	3,193
Other Current Assets	5,363	4,277	105	3,722	2,567
Total Current Assets	25,054	22,593	26,244	19,544	15,563
Property, Plant & Equipment	10,502	9,449	10,171	8,917	8,335
Long-Term Investments	1,657	903	1,168	987	610
Goodwill	20,048	19,820	19,997	11,845	11,668
Intangible Assets	38,089	39,307	42,387	20,947	20,833
Other Long-Term Assets	5,769	4,411	5,396	4,489	4,368
Total Long-Term Assets	76,065	73,890	79,119	47,185	45,814
Total Assets	101,119	96,483	105,363	66,729	61,377
Accounts Payable	3,267	19,040	18,938	15,785	13,987
Current Debt	5,400	5,542	1,893	2,386	2,010
Other Current Liabilities	21,875	1,711	1,763	2,136	2,120
Total Current Liabilities	30,542	26,293	22,594	20,307	18,117
Long-Term Debt	23,222	23,690	28,888	17,994	16,217
Other Long-Term Liabilities	8,189	9,442	14,594	12,790	12,447
Total Long-Term Liabilities	31,411	33,132	43,482	30,784	28,664
Total Liabilities	61,953	59,425	66,076	51,091	46,781
Total Debt	28,622	29,232	30,781	20,380	18,227
Debt Growth	-2.09%	-5.03%	51.04%	11.81%	-4.64%
Common Stock	388	387	387	328	328
Retained Earnings	1,502	-574	1,710	5,299	2,812
Comprehensive Income	-949	-1,625	111	881	-143
Shareholders' Equity	39,143	37,037	39,268	15,622	13,127
Total Liabilities and Equity	101,119	96,483	105,363	66,729	61,377
Net Cash / Debt	-22,762	-22,827	-24,383	-12,388	-12,009
Net Cash Per Share	-14.57	-14.63	-17.09	-9.43	-9.23
Working Capital	-5,488	-3,700	3,650	-763	-2,554
Book Value Per Share	25.27	23.93	27.69	11.91	10.09

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.